Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The milligram figure is route-specific, not a stronger dose than the injection
This metabolic boost helps: Break through weight loss plateaus Accelerate fat loss Improve energy expenditure in individuals with sluggish metabolism This is achieved through beta-3 adrenergic receptor activation in fat cells, which increases lipolysisthe breakdown of fat into usable energy substrates 3
Regulation of acetyl-CoA carboxylase
Once you ingest vitamin B12, it is processed by acids and enzymes in the stomach and small intestine
| Agent | FDA Approval | Mean Weight Loss (RCT) | Route | |---|---|---|---| | Semaglutide 2.4 mg (Wegovy) | Yes (2021) | 14.9% at 68 weeks (STEP-1, N=1,961) [9] | Subcutaneous weekly | | Tirzepatide 15 mg (Zepbound) | Yes (2023) | 20.9% at 72 weeks (SURMOUNT-1, N=2,539) [11] | Subcutaneous weekly | | AOD-9604 1 mg oral | No | ~2.8 kg at 12 weeks (Phase IIb, N=300 approx.) [1] | Oral (not currently compounded) | The weight-loss magnitude from the single Phase IIb AOD-9604 trial is substantially smaller than what STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide) demonstrated in larger, longer trials
US$ 27.00
US$ 28.83
US$ 27.34
US$ 25.30
